Srushti Shah

Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer

A. Mahajan, S. Ghosh-Laskar, K. Prabhash, 2016, Oncology research.

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.

A. Dutt, Rajiv Kumar, A. Mahajan, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of chemotherapy in patients with small cell lung cancer and poor performance status

A. Mahajan, K. Prabhash, V. Noronha, 2020, Acta oncologica.

Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).

A. Dutt, Rajiv Kumar, A. Mahajan, 2019, Journal of Clinical Oncology.

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings

A. Mahajan, K. Prabhash, V. Noronha, 2021, Ecancermedicalscience.

Deviation from standard cancer treatment during the first wave of the COVID-19 pandemic in India: A cross-sectional study

K. Prabhash, V. Noronha, V. Patil, 2022, Cancer Research, Statistics, and Treatment.

Dexamethasone and exercise for cancer-related fatigue: A phase III randomized controlled trial.

K. Prabhash, V. Noronha, V. Patil, 2023, Journal of Clinical Oncology.

Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.

S. Kannan, A. Bhattacharjee, K. Prabhash, 2020, Chest.